The Net Margin of IX Biopharma Ltd (42C.SI) is -181.14%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-06-30 | -181.14% |
| 2023-06-30 | -162.61% |
| 2022-06-30 | -31.95% |
| 2021-06-30 | -471.86% |
| 2020-06-30 | -1065.89% |
| 2019-06-30 | -445.75% |
| 2018-06-30 | -6135.77% |
| 2017-06-30 | -115.81% |
| 2016-06-30 | -132.88% |
| 2015-06-30 | -141.85% |